Soleno Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
April 03 2019 - 8:00AM
Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a
clinical-stage biopharmaceutical company developing novel
therapeutics for the treatment of rare diseases, today announced
that Anish Bhatnagar, M.D., Chief Executive Officer, will present
at the 2019 H.C. Wainwright Global Life Sciences Conference on
Monday, April 8, 2019, at 4:50 PM BST / 11:50 AM ET, in London,
United Kingdom. A webcast of the presentation will be
available here: http://wsw.com/webcast/hcw4/slno/.
About Soleno Therapeutics, Inc.Soleno is
focused on the development and commercialization of novel
therapeutics for the treatment of rare diseases. The company’s lead
candidate, DCCR, a once-daily oral tablet for the treatment of PWS,
is currently being evaluated in a Phase III clinical development
program.
For more information, please visit www.soleno.life.
CONTACT:Brian RitchieLifeSci Advisors,
LLC212-915-2578
Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Apr 2023 to Apr 2024